VEA
Virtus ETF Advisers’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,533
| Closed | -$63.3K | – | 592 |
|
|
2024
Q4 | $63.3K | Buy |
+3,533
| New | +$63.3K | 0.03% | 433 |
|
|
2022
Q2 | – | Sell |
-49,234
| Closed | -$61K | – | 468 |
|
|
2022
Q1 | $61K | Sell |
49,234
-2,911
| -6% | -$3.61K | 0.03% | 358 |
|
|
2021
Q4 | $170K | Buy |
52,145
+9,712
| +23% | +$31.7K | 0.06% | 286 |
|
|
2021
Q3 | $177K | Sell |
42,433
-2,215
| -5% | -$9.24K | 0.08% | 298 |
|
|
2021
Q2 | $187K | Sell |
44,648
-50,681
| -53% | -$212K | 0.08% | 377 |
|
|
2021
Q1 | $431K | Buy |
95,329
+1,674
| +2% | +$7.57K | 0.18% | 168 |
|
|
2020
Q4 | $284K | Sell |
93,655
-21,361
| -19% | -$64.8K | 0.12% | 239 |
|
|
2020
Q3 | $285K | Sell |
115,016
-15,680
| -12% | -$38.9K | 0.15% | 235 |
|
|
2020
Q2 | $371K | Buy |
+130,696
| New | +$371K | 0.18% | 235 |
|
|
2018
Q4 | – | Sell |
-38,458
| Closed | -$598K | – | 366 |
|
|
2018
Q3 | $598K | Sell |
38,458
-28,243
| -42% | -$439K | 0.06% | 101 |
|
|
2018
Q2 | $884K | Buy |
+66,701
| New | +$884K | 0.78% | 13 |
|